A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment

Galina A. Gusarova(Columbia University), Robert H. Costa(University of Illinois Chicago)

Journal of Clinical Investigation

December 15, 2006

10.1172/jci27527

Cited by 155

Related Papers

Earlier Expression of the Transcription Factor Hfh–11B Diminishes Induction of P21Cip1/Waf1 Levels and Accelerates Mouse Hepatocyte Entry Into S–Phase Following Carbon Tetrachloride Liver Injury

|Hepatology|2001|89

Actin fence therapy with exogenous V12Rac1 protects against acute lung injury

|JCI Insight|2021|10

Actin fence therapy with exogenous V12Rac1 protects against Acute Lung Injury

|bioRxiv (Cold Spring Harbor Laboratory)|2021|0

High CO 2 Levels Cause Skeletal Muscle Atrophy via AMP-activated Kinase (AMPK), FoxO3a Protein, and Muscle-specific Ring Finger Protein 1 (MuRF1)

|UNC Libraries|2020|0